Abstract:Research highlights • Profound perturbation of metabolome preceding T2D onset was revealed in a prospective Chinese population-based cohort with a follow-up period of almost 16 years. • Insulin resistance rather than β-cell dysfunction was strongly associated with metabolic shifts before T2D. • The impact of metabolites on T2D risk could be mediated by insulin resistance. • Discovery of previously unknown independent associations between metabolites and incident T2D. • The inclusion of metabolites selected by machine learning significantly improved the predictive power of traditional clinical prediction models. Introduction Type 2 diabetes (T2D) is a heterogeneous metabolic disease with large variations in the relative contributions of insulin resistance and β-cell dysfunction across different glucose tolerance subgroups and ethnicities. A more precise yet feasible approach to categorize risk preceding T2D onset is urgently needed. This study aimed to identify potential metabolic biomarkers that could contribute to the development of T2D and investigate whether their impact on T2D is mediated through insulin resistance and β-cell dysfunction. Methods A non-targeted metabolomic analysis was performed in plasma samples of 196 incident T2D cases and 196 age- and sex-matched non-T2D controls recruited from a long-term prospective Chinese community-based cohort with a follow-up period of ∼16 years. Results Metabolic profiles revealed profound perturbation of metabolomes before T2D onset. Overall metabolic shifts were strongly associated with insulin resistance rather than β-cell dysfunction. In addition, 188 out of the 578 annotated metabolites were associated with insulin resistance. Bi-directional mediation analysis revealed putative causal relationships among the metabolites, insulin resistance and T2D risk. We built a machine-learning based prediction model, integrating the conventional clinical risk factors (age, BMI, TyG index and 2hG) and 10 metabolites (acetyl-tryptophan, kynurenine, γ-glutamyl-phenylalanine, DG(18:2/22:6), DG(38:7), LPI(18:2), LPC(P-16:0), LPC(P-18:1), LPC(P-20:0) and LPE(P-20:0)) (AUROC = 0.894, 5.6% improvement comparing to the conventional clinical risk model), that successfully predicts the development of T2D. Conclusions Our findings support the notion that the metabolic changes resulting from insulin resistance, rather than β-cell dysfunction, are the primary drivers of T2D in Chinese adults. Metabolomes as a valuable phenotype hold potential clinical utility in the prediction of T2D. Graphical abstract Download : Download high-res image (106KB) Download : Download full-size image

Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline

Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults.

Plasma Metabolomics Identified Novel Metabolites Associated with Risk of Type 2 Diabetes in Two Prospective Cohorts of Chinese Adults.

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank

Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study

Serum metabolomic profiling of incident type 2 diabetes mellitus in the Multi-Ethnic Study of Atherosclerosis and Rotterdam Study

Biomarker Profiling with Targeted Metabolomic Analysis of Plasma and Urine Samples in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease

Metabolomics in human type 2 diabetes research

Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy

Proteomics profiling and association with cardiorenal complications in type 2 diabetes subtypes in Asian population

Metabolic Profiles of Type 2 Diabetes and Their Association with Renal Complications.

Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk

Plasma Metabolomic Profiles in Association with Type 2 Diabetes Risk and Prevalence in Chinese Adults

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes

Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose

Metabolic Signature Shift in Type 2 Diabetes Mellitus Revealed by Mass Spectrometry-Based Metabolomics.

Metabolite Profiling of the Gut–Renal–Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients

Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease

Machine Learning Approaches Reveal Metabolic Signatures of Incident Chronic Kidney Disease in Individuals With Prediabetes and Type 2 Diabetes

Ten metabolites-based algorithm predicts the future development of type 2 diabetes in Chinese